Table 1 Patient Demographics
Intervention Group (n = 20) | Usual Care Group (n = 20) | Total (N = 40) | P-value | |
|---|---|---|---|---|
Age | 0.23 | |||
Mean (SDa) | 66.55 (7.28) | 63.20 (9.80) | 64.88 (8.69) | |
Median (Range) | 68.5 (55.0–79.0) | 63.5 (42.0–78.0) | 66.0 (42.0–79.0 | |
Duration Between Cancer Diagnosis and Enrollment (median, range, years) | 1.6 (0.1–6.0) | 2.2 (0.2–10.7) | 1.9 (0.1–10.7) | 0.14 |
Sex | 0.03 | |||
Female | 12 (60%) | 18 (90%) | 30 (75%) | |
Male | 8 (40%) | 2 (10%) | 10 (25%) | |
Race | 0.66 | |||
White | 18 (90%) | 16 (80%) | 34 (85%) | |
Other | 2 (10%) | 4 (20%) | 6 (15%) | |
Body Mass Index (mean, SD) | 27.75 (8.44) | 26.52 (5.73 | 27.13 (7.14) | 0.59 |
Highest level of education completed | 0.17 | |||
High School | 8 (40%) | 4 (20%) | 12 (30%) | |
College and above | 12 (60%) | 16 (80%) | 28 (70%) | |
Marital Status | 0.74 | |||
Married or Living with Partner | 13 (65%) | 12 (60%) | 25 (62.5%) | |
Divorce, Widowed, Living Alone | 7 (35%) | 8 (40%) | 15 (37.5%) | |
Work Status | 0.61 | |||
Employed full-time | 7 (35%) | 5 (25%) | 12 (30%) | |
Employed part-time | 2 (10%) | 1 (5%) | 3 (7.5%) | |
Other | 11 (55%) | 14 (70%) | 25 (62.5%) | |
Cancer Type | 0.49 | |||
Adenocarcinoma | 18 (90%) | 15 (75%) | 33 (82.5%) | |
Squamous Cell Carcinoma | 1 (5%) | 2 (10%) | 3 (7.5%) | |
Other or Mixed Histology | 1 (5%) | 3 (15%) | 4 (10%) | |
Stage | 0.77 | |||
IIIA | 3 (15%) | 2 (10%) | 5 (12.5%) | |
IIIB | 2 (10%) | 4 (20%) | 6 (15%) | |
IV | 15 (75%) | 14 (70%) | 29 (72.5%) | |
Performance Status | 1.00 | |||
ECOG 0 | 3 (15%) | 4 (20%) | 7 (17.5%) | |
ECOG 1 | 17 (85%) | 16 (80%) | 33 (82.5%) | |
Tobacco Smoking History | 0.69 | |||
Current Smoker | 1 (5%) | 0 (0%) | 1 (2.5%) | |
Former Smoker | 16 (80%) | 15 (75%) | 31 (77.5%) | |
Never Smoker | 3 (15%) | 5 (25%) | 8 (20%) | |
Cancer Treatment Status | 0.23b | |||
Receiving Treatment | 16 (80%) | 18 (90%) | 34 (85%) | |
Chemotherapy only | 2 | 2 | 4 | |
Chemo-immunotherapy | 5 | 1 | 6 | |
Immunotherapy only | 6 | 8 | 14 | |
Targeted therapy | 3 | 7 | 10 | 0.66c |
Post-treatment | 4 (20%) | 2 (10%) | 6 (15%) | |